Clinic
Baylor Scott & White Medical Center - Centennial
Baylor Scott & White Medical Center - Centennial was paid $476K by Medicaid between Mar 2021 and Nov 2024, across 30 billing codes. Its largest line is 99284, emergency room visit (serious) — 66% of everything it billed.
33Billing provider infoBAYLOR SCOTT & WHITE MEDICAL CENTER - CENTENNIAL
FRISCO, TX 75035
FRISCO, TX 75035
33aNPI1801826839assigned 07/04/2006
33bProvider typeAmbulatory Surgical Clinic/Center
28Total paid$476K
24GClaims12,481
24DCodes billed30
24AFirst – last monthMar 2021 – Nov 2024
Compared with peers
Next to other Ambulatory Surgical Clinic/Center providers in Texas
Rank by total paid#145 of 320
Median peer was paid$205K
This provider vs. median2.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 2,365 | $83K | |
| 2022 | 4,613 | $215K | |
| 2023 | 3,290 | $106K | |
| 2024incomplete | 2,213 | $72K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 66% | 1,424 | 1,274 | $315K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 8.4% | 131 | 120 | $40K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 6.7% | 727 | 612 | $32K |
| 71045 | Radiologic examination, chest; single view | 4.4% | 799 | 705 | $21K |
| 80053 | Comprehensive metabolic panel | 3.6% | 1,771 | 1,445 | $17K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.6% | 1,994 | 1,553 | $13K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 2.5% | 498 | 459 | $12K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 1.7% | 148 | 139 | $8K |
| 84484 | 1.4% | 615 | 475 | $7K | |
| 83880 | <1% | 42 | 38 | $2K | |
| 81001 | <1% | 629 | 572 | $2K | |
| 83690 | <1% | 318 | 271 | $2K |
18 more codes
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 26 | $2K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 28 | $1K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 26 | $1K |
| 84703 | <1% | 72 | $750.11 | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 57 | $730.38 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 26 | $500.36 |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,962 | $471.87 |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 12 | $256.80 |
| 83735 | <1% | 58 | $244.27 | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 44 | $211.67 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 306 | $165.34 |
| 85610 | <1% | 57 | $160.20 | |
| 85730 | <1% | 28 | $142.14 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 93 | $72.34 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 18 | $69.44 |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 12 | $18.59 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 544 | $0.00 |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGEBHART, JACOB (CEO)